Crossmark Global Holdings Inc. Has $995,000 Stock Position in The Clorox Company (NYSE:CLX)

Crossmark Global Holdings Inc. cut its holdings in shares of The Clorox Company (NYSE:CLX) by 4.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,107 shares of the company’s stock after selling 268 shares during the period. Crossmark Global Holdings Inc.’s holdings in Clorox were worth $995,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in CLX. State Board of Administration of Florida Retirement System lifted its holdings in shares of Clorox by 4.1% in the first quarter. State Board of Administration of Florida Retirement System now owns 150,011 shares of the company’s stock valued at $23,738,000 after purchasing an additional 5,936 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in Clorox by 9.4% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 186,301 shares of the company’s stock worth $28,525,000 after acquiring an additional 16,012 shares during the last quarter. Mizuho Markets Americas LLC grew its stake in shares of Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after acquiring an additional 34,864 shares in the last quarter. First Foundation Advisors bought a new stake in shares of Clorox in the 1st quarter worth $31,000. Finally, Mitsubishi UFJ Trust & Banking Corp lifted its position in shares of Clorox by 24.3% during the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 181,772 shares of the company’s stock valued at $27,711,000 after purchasing an additional 35,477 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. upped their target price on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. DA Davidson lifted their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Evercore ISI reduced their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Five investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $155.00.

Clorox Stock Performance

Shares of CLX stock opened at $165.74 on Friday. The firm’s 50 day moving average is $162.38 and its 200 day moving average is $147.21. The stock has a market capitalization of $20.52 billion, a P/E ratio of 57.62, a PEG ratio of 3.04 and a beta of 0.41. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $169.09. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the business posted $0.49 earnings per share. The business’s quarterly revenue was up 27.0% on a year-over-year basis. On average, sell-side analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.94%. The ex-dividend date was Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 170.04%.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.57% of the stock is owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.